Recruitment milestone reached in Diamyd® Phase 3 trial ...Middle East

PR Newswire - News
STOCKHOLM, April 12, 2024 /PRNewswire/ -- Diamyd Medical's precision medicine Phase 3 trial for Type 1 Diabetes, DIAGNODE-3, has enrolled 100 patients. To date, no serious adverse events have been reported, and no patients have discontinued the trial. "This is an important milestone in...

Hence then, the article about recruitment milestone reached in diamyd phase 3 trial was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Recruitment milestone reached in Diamyd® Phase 3 trial )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News